NCT05838235

Brief Summary

This research study aims to evaluate the effect of a 6-month adapted physical activity program (APA) on the endurance capacities (evaluated as the maximum oxygen consumption \[VO2 peak\] on a cardiopulmonary exercise test) of children and adolescents with Marfan syndrome or related.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
29mo left

Started Apr 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Apr 2023Oct 2028

First Submitted

Initial submission to the registry

March 31, 2023

Completed
24 days until next milestone

Study Start

First participant enrolled

April 24, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 1, 2023

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2028

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2028

Last Updated

March 3, 2026

Status Verified

March 1, 2026

Enrollment Period

4.9 years

First QC Date

March 31, 2023

Last Update Submit

March 2, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Measurement of maximum endurance

    maximum oxygen consumption (VO2 peak) during a cardiopulmonary exercise test will be measured

    At baseline

  • Measurement of maximum endurance

    maximum oxygen consumption (VO2 peak) during a cardiopulmonary exercise test will be measured

    Up to 6 month

Study Arms (1)

6 month adapted physical activity

EXPERIMENTAL

The various assessments will be carried out during 2 visits at 6 months interval as part of the usual follow-up at the Toulouse University Hospital. Standard cardiopulmonary exercise test assessment will be coupled with an assessment by an APA coach on the same day. The APA program built from the initial assessment will be returned to the child and his family during a videoconference. In addition, a regular reassessment and adjustment of this program will be made every 15 days during phone calls by the APA coach.

Other: Adapted Physical Activity program

Interventions

The Adaptated Physical Activity program will consist of a Personalized Training Program

6 month adapted physical activity

Eligibility Criteria

Age7 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Genetically confirmed Marfan syndrome or related syndrome
  • Girl or boy aged 7 to 17
  • Informed and written consent signed by at least one of the two holders of parental authority
  • Patient affiliated to a social security scheme or equivalent

You may not qualify if:

  • Cardiac contraindications to the APA program:
  • Severe aortic dilation (aortic diameter \> 45 mm)
  • and/or left ventricular failure (left ventricular ejection fraction \<45%)
  • and/or severe mitral leakage ≥ grade 3
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Toulouse

Toulouse, France

RECRUITING

MeSH Terms

Conditions

Marfan Syndrome

Condition Hierarchy (Ancestors)

Bone Diseases, DevelopmentalBone DiseasesMusculoskeletal DiseasesHeart Defects, CongenitalCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGenetic Diseases, InbornConnective Tissue DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Thomas EDOUARD, MD

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Fernanda BAJANCA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 31, 2023

First Posted

May 1, 2023

Study Start

April 24, 2023

Primary Completion (Estimated)

April 1, 2028

Study Completion (Estimated)

October 1, 2028

Last Updated

March 3, 2026

Record last verified: 2026-03

Locations